PubMed · 2016 · 10 citations · 0 references
Life SciencesEndocrinologyImmunologyCell SignalingInflammationSignal TransductionCytokine BiologyInflammatory ProcessesInflammatory Response RegulationInflammatory SignalingOsteoarthritisSteroid Hormone SignalingAnti-inflammatory MechanismsEstrogen ImmunomodulationEstrogen Receptor ExpressionEstrogen ReceptorsMatched Control GroupNf-κb SignalingNuclear Factor Kappa B ModulationProtein Expression Levels
mol/L tetrahydrocannabinol (THC). Thirty-six hours later, we observed the mRNA and protein levels of IκBα, phospho-IκBα (p-IκBα) and IL-6. Results Immunofluorescence staining showed the high expression level of ERβ in synovicytes. In IL-1β treated cells, IL-6 mRNA and protein level, IκBα mRNA and p-IκBα protein levels were elevated compared with the control group, while IκBα protein level declined. In the cells pretreated with IL-1β and estrogen, the mRNA and protein levels of IL-6, IκBα and p-IκBα were inhibited compared with IL-1β treated cells. THC blocked the effects of estrogen on the IL-1β and estrogen treated cells, and the mRNA and protein levels of IL-6, IκBα and p-IκBα had no significant difference compared with IL-1β treated cells. Conclusion The estrogen can restrain the activation of NF-κB pathway in synovicytes via ERβ, thus playing a vital role in anti-inflammation.